Chantix
Product Images NDC 50090-0995

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 50090-0995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical structure diagram of the active ingredient in CHANTIX. The diagram shows a bicyclic system with nitrogen atoms and a separate component with carboxyl and hydroxyl groups, reflecting the molecular structure associated with the active compound in this medication.*

FDA Label Image

Figure 1 (Chantix 02)

A bar chart comparing the efficacy or outcome percentages across different studies labeled Study 2 through Study 5. Each study compares CHANTIX at various dosages and formulations against placebo or bupropion SR, with percentages marked along the y-axis and the studies and treatments labeled on the x-axis. Error bars are shown for each comparison point.*

FDA Label Image

Figure 2 (Chantix 03)

A bar graph comparing the percentage values across five studies for CHANTIX at various dosages (0.5 mg BID, 1.0 mg BID, flexible), bupropion SR 150 mg BID, and placebo. Error bars are present to indicate variability. The vertical axis shows percentages from 0% to 35%, and each study groups show results for the different treatments or placebo.*

FDA Label Image

Figure 3 (Chantix 04)

A line graph comparing the percentage of continuous abstinent subjects over weeks of nontreatment follow-up between CHANTIX 1.0 mg BID and placebo groups. The x-axis represents weeks, and the y-axis represents the percentage of continuous abstinent. Two lines show a higher percentage of abstinence for CHANTIX compared to placebo during follow-up.*

FDA Label Image

Logo (Chantix 05)

FDA Label Image

Logo (Chantix 06)

FDA Label Image

Label Image (Lbl500900995)

CHANTIX packaging label from A-S Medication Solutions, NDC 50090-0995. Each tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. The package contains 4 continuing weeks of treatment with 1 mg x 56 tablets. Storage instructions indicate to keep at 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.